Impact of rheumatoid arthritis patient eligibility for Tumour Necrosis factor inhibitor therapy (as per NICE guidance concerning disease activity) on need for joint replacement: a regression discontinuity study

Slični predmeti

• Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: an interrupted time-series analysis
  od: Hawley, S, i dr.
  Izdano: (2017)
• Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data
  od: Hawley, S, i dr.
  Izdano: (2018)
• Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
  od: Hawley, S, i dr.
  Izdano: (2019)
• Diagnosis and management of endometriosis: summary of NICE guidance
  od: Kuznetsov, L, i dr.
  Izdano: (2017)
• NICE guidance to working with real-world data
  od: A. Sh. Motrinchuk, i dr.
  Izdano: (2023-01-01)